Skip to main content

Table 5 Seroprevalence of anti-HEV IgM among population with chronic hepatitis B infection in Rushan county, Shandong province, China

From: Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China

  Number detected Positive number Positive rate (%, 95% CI) P value
Total 1022 16 1.57 (0.90–2.53)
Age group (yrs)
 Under 30 66 0 0 (0–5.44) 0.768
 30–39 79 1 1.26 (0.03–6.85)  
 40–49 242 6 2.48 (0.92–5.32)  
 50–59 336 5 1.49 (0.48–3.44)  
 60–69 211 3 1.42 (0.29–4.10)  
 Above 70 88 1 1.14 (0.03–6.17)  
Gender
 Male 516 8 1.55 (0.67–3.03) 0.969
 Female 506 8 1.58 (0.68–3.09)  
Clinical typea
 HBV carrier 838 12 1.43 (0.74–2.49) 0.060#
 Chronic cases 74 0 0 (0–4.86)  
 Cirrhosis 8 0 0 (0–36.94)  
 HCC 3 1 33.33 (0.84–90.57)  
  1. HBV hepatitis B virus, HCC hepatic cellular cancer
  2. # Fisher’s exact test
  3. aNinety nine participants with unknown clinical type were not involved in the analysis